SARS-CoV-2 Spike Antikörper (RBD)
-
- Target Alle SARS-CoV-2 Spike Antikörper anzeigen
- SARS-CoV-2 Spike
-
Bindungsspezifität
- RBD
-
Reaktivität
- SARS Coronavirus-2 (SARS-CoV-2)
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SARS-CoV-2 Spike Antikörper ist unkonjugiert
-
Applikation
- ELISA, Neutralization (Neut), Western Blotting (WB)
- Aufreinigung
- Greater than 95% as determined by reducing SDS-PAGE.
- Immunogen
- S-RBD recombinant protein
- Top Product
- Discover our top product SARS-CoV-2 Spike Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:320000, WB: 1:1000~2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 10 % glycerol, pH 7.2
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,4 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
- Target
- SARS-CoV-2 Spike
- Abstract
- SARS-CoV-2 Spike Produkte
- Synonyme
- E2 antikoerper, E2 glycoprotein precursor antikoerper, Surface Glycoprotein antikoerper, S antikoerper
- Substanzklasse
- Viral Protein
- Hintergrund
- SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.
- Gen-ID
- 43740568
-